Guest guest Posted November 18, 2005 Report Share Posted November 18, 2005 Below I cut and paste some of the info that doctors are supposed to do when you report illness accociated with mold. They certainly are not supposed to ignore this situation. Good info. I have read up to Page 51. I have more info that is related to symptoms I have on record and are allergic related but very informative if you want more that I cut and pasted. A Public Health Model: The Sentinel Case Once a building relationship is established, the healthcare provider is encouraged to exclude a more general public health problem related to the building. Without requesting names, the provider should ask whether other individuals in the building have similar symptoms. In many states, physicians must report occupational diseases of any type to the state department of health or labor. In all states, if multiple individuals are involved, the conditions should be reported to the state health department, and an industrial hygienist or someone with experience in evaluating buildings for building-related illnesses should evaluate the building to identify the cause of the illness. Sources of water intrusion and mold amplification need to be identified and recommendations for repairs need to be made. The toxicity of mold products in humans is best documented in situations involving ingestion of moldy foods, direct skin contact with concentrated toxins, and inhalation of molds at very high concentrations. In recent years, there have been numerous reports in both the medical literature and the popular media that indoor exposure to fungi or fungal toxins has caused significant disease or death in the occupants of water damaged homes or workplaces. These locations had significant (generally visible) fungal growth and odors, typically reported as from the " black mold, " Stachybotrys chartarum. (It should be noted here that many molds are " black " in appearance.) S. chartarum is a ubiquitous organism, growing on cellulose products exposed to water or high humidity. In moist buildings, S. chartarum frequently grows on wallpaper, wallboard, ceiling tiles, carpets (especially those with jute backing), insulation (e.g., urea–formaldehyde foam) in the spaces between inner and outer walls, around leaking window frames or water pipes, and in HVAC air ducts containing lint or other organic debris. While we focus on mold, we want to emphasize that the risk factor clearly associated with symptoms and illness is chronic or severe moisture incursion into buildings with subsequent growth of microbial agents. The potential role of bacterial agents, dust mites, and pests associated with moisture in buildings should not be ignored. Patients Whose Conditions Warrant an Environmental Assessment Because They Are Frequently Induced by Environmental Factors, Including Moisture and Mold Table A lists medical conditions that, in the absence of an alternative explanation, should prompt an environmental history especially with inquiries about possible exposure to moisture and molds. New onset and exacerbated asthma, interstitial lung disease, hypersensitivity pneumonitis, sarcoidosis, and pulmonary hemorrhage in infants are conditions that can lead to chronic, progressive disease or death if an etiologic agent is responsible and not recognized. We also suggest that healthcare providers consider pursuing an environmental history with patients who have any of the three precursor conditions listed on the right hand side of the table: mucosal irritation, recurrent rhinitis/sinusitis, and recurrent hoarseness. While they are in themselves of less importance to overall health, their presence in an individual who seeks care because of exposures in an environment of concern would warrant intervention to prevent progression to more serious illness in the future. If a patient has a condition listed in Table A, then the physician may proceed to the questions in Table C to explore possible environmental exposures. A Note on the Health Effects of Mold The majority of reactions to mold and moisture in the environment are allergic in nature and manifest themselves as asthma or allergic rhinitis. Delayed hypersensitivity is not uncommon and often less well recognized and manifests as chronic rhinitis, sinusitis, or hypersensitivity pneumonitis. Moisture in buildings has been associated with an irritant symptom complex: headache, drowsiness, occasionally cough, dermatitis, and most often burning and irritation of the eyes, nose, and throat. The term " sick building syndrome " is commonly used to describe these irritant symptoms if they resolve, sometimes immediately, without long-term consequences, after the person leaves the environment. Although toxic syndromes are not well defined from inhalation exposure of mold or mold products in indoor environments, many patients and some physicians have attributed cognitive and other neurological syndromes to mold exposures. There is no consensus as to the nature, pathophysiology, or etiology of these syndromes. (See chapter 4 and Appendix B for discussion on health effects of molds.) Administrative issues arise when the environment of concern is a place of work (worker's compensation), a school, a rented home, or a situation insured against loss related to mold or moisture. Healthcare providers need to provide clear documentation regarding diagnosis, temporal relationships of symptoms, and findings relative to exposures and conclusions. Environmental intervention could be a " fix-it " solution to eliminate moisture incursion and moldy materials by, for example, repairing a leaky roof and replacing damaged materials, or it could involve a program of improved maintenance. (Remediation is discussed in chapters 6 and 7.) It has been shown that patients with upper respiratory allergic syndromes, who work in buildings with significant airborne loads of fungal antigens, can have their symptoms resolve after the reservoirs of fungal organisms are eliminated by instituting a more rigorous maintenance program for the building's heating, ventilation, and air-conditioning (HVAC) system (Hiipakka and Buffington 2000). After remediation, clinical follow-up is critical in evaluating the success of the intervention. Frequently, the offending mold can be decreased to a tolerable level, but once an individual is sensitized, this may not always be possible. Unfortunately, current methods of mold detection are not sensitive or quantitative enough to be able to determine if the exposure has been sufficiently decreased. The only assessment for someone very sensitized to mold is to allow the individual to return to the environment and monitor his or her condition carefully to determine if there is an exacerbation of symptoms. Once an individual has developed asthma, the asthma may not subside completely, even when exposure to the original agent has ceased (Chan-Yeung and Lam 1986, Chan-Yeung and Malo 1995). So, one must monitor the severity of asthmatic symptoms and the quantity and type of medications that are required for asthma control. The severity of the asthma must be carefully assessed according to the Asthma Task Force Guidelines (NHLB 1997) and the patient must be treated accordingly until the symptoms are stable at the lowest level of severity. At that point, the patient may be returned, on a trial basis and with careful oversight to detect exacerbation, to the remediated building. The medical management of allergic and irritant syndromes is no different for those related to mold exposure than for other types. Antihistamines, inhaled nasal corticosteroids, and inhaled pulmonary corticosteroids can be prescribed as needed. The clinician needs to be aware of the possibility that symptoms are suppressed in the setting of ongoing exposure to pertinent agents, particularly antigens. This may result in greater morbidity over the long term because removal from the environment of concern may not occur. Concomitant use of medical therapy during evaluation and remediation of an environment is, however, not only acceptable but important in the recovery of the individual. Quote Link to comment Share on other sites More sharing options...
Guest guest Posted November 18, 2005 Report Share Posted November 18, 2005 Do you have a link or reference to tte full document, please? ldelp84227 <ldelp84227@...> wrote: Below I cut and paste some of the info that doctors are supposed to do when you report illness accociated with mold. They certainly are not supposed to ignore this situation. Good info. I have read up to Page 51. I have more info that is related to symptoms I have on Serena There is no such thing as an anomaly. Recheck your original premise. ...Ayn Rand, paraphrased --------------------------------- FareChase - Search multiple travel sites in one click. Quote Link to comment Share on other sites More sharing options...
Guest guest Posted November 18, 2005 Report Share Posted November 18, 2005 -Serena, Do you have site. Here it is posted by Sharon originally. http://www.oehc.uchc.edu/clinser/MOLD GUIDE.pdf > Do you have a link or reference to tte full document, please? > > > ldelp84227 <ldelp84227@a...> wrote: > Below I cut and paste some of the info that doctors are supposed to > do when you report illness accociated with mold. They certainly are > not supposed to ignore this situation. Good info. I have read up to > Page 51. I have more info that is related to symptoms I have on > > > > Serena > > There is no such thing as an anomaly. Recheck your original premise. > ...A yn Rand, paraphrased > > > > > --------------------------------- > FareChase - Search multiple travel sites in one click. > > Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.